See what we’re reading this week at Global Biodefense on topics including curbing the threat of MERS-CoV, BARDA medical countermeasure contracts, and a look at how the 1918 pandemic revolutionized public health. [Read more]
See what we’re reading this week at Global Biodefense on topics including a National Academies’ report on Dual Use Research of Concern, antibody therapeutics for ricinosis, and questions on inhaled flu vaccine [Read more]
The Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical and Biological Defense, has announced the development of a Biological Select Agents and Toxins (BSAT) [Read more]
Elusys Therapeutics, Inc. has received payment from the U.S. federal government for completing the second delivery of its medical countermeasure for inhalational anthrax, according to a Jan. 24 statement by the company. [Read more]
See what we’re reading this week at Global Biodefense on topics including improving biosurveillance systems, turning competitors into collaborators during epidemics, and therapeutic windows for ricin post-exposure treatment. BIOPREPAREDNESS Using the lessons of economics [Read more]
Emergent BioSolutions Inc. this week announced that the U.S. Department of Health and Human Services (HHS) is advancing its anthrax preparedness strategy with multiple contract actions for the company’s anthrax vaccines. On [Read more]
See what we’re reading this week at Global Biodefense on topics including CRISPR bioterror potential, accidental live anthrax use during CDP training, and global action plan for antimicrobial resistance. POLICY, PRACTICES & POLITICS Officials [Read more]
The U.S. Environmental Protection Agency has published a report focused on decontaminating railcars and related materials in the event of a biological incident in a subway system. In the event of a [Read more]
See what we’re reading this week at Global Biodefense on topics including pandemic simulations, Canada’s anthrax vaccine stockpile, animal feed biosecurity, and CRISPR’s promise for better animal models. BIOPREPAREDNESS Assessing the epidemic potential of [Read more]
An Environmental Protection Agency (EPA) study, conducted by the EPA’s Office of Research and Development National Homeland Security Research Center (NHSRC), examined methods for decontamination of drinking water infrastructure contaminated with anthrax-like [Read more]
© 2019 STEMAR MEDIA